Renaissance Technologies’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $49.8K | Buy |
+40,468
| New | +$57.8K | ﹤0.01% | 3048 |
|
|
2025
Q3 | – | Sell |
-17,800
| Closed | -$50.6K | – | 3877 |
|
|
2025
Q2 | $50.6K | Buy |
+17,800
| New | +$53.8K | ﹤0.01% | 3391 |
|
|
2023
Q4 | – | Sell |
-700
| Closed | -$11K | – | 4102 |
|
|
2023
Q3 | $11K | Sell |
700
-410
| -37% | -$8.01K | ﹤0.01% | 3579 |
|
|
2023
Q2 | $24K | Sell |
1,110
-988
| -47% | -$20.3K | ﹤0.01% | 3742 |
|
|
2023
Q1 | $41K | Sell |
2,098
-1,625
| -44% | -$41.9K | ﹤0.01% | 3705 |
|
|
2022
Q4 | $83K | Sell |
3,723
-45
| -1% | -$1.6K | ﹤0.01% | 3680 |
|
|
2022
Q3 | $161K | Sell |
3,768
-20
| -0.5% | -$1.17K | ﹤0.01% | 3453 |
|
|
2022
Q2 | $221K | Buy |
3,788
+770
| +26% | +$49.3K | ﹤0.01% | 3610 |
|
|
2022
Q1 | $242K | Sell |
3,018
-95
| -3% | -$6.87K | ﹤0.01% | 3564 |
|
|
2021
Q4 | $284K | Sell |
3,113
-1,420
| -31% | -$152K | ﹤0.01% | 3365 |
|
|
2021
Q3 | $506K | Sell |
4,533
-75
| -2% | -$9.23K | ﹤0.01% | 2887 |
|
|
2021
Q2 | $677K | Sell |
4,608
-333
| -7% | -$52.3K | ﹤0.01% | 2835 |
|
|
2021
Q1 | $734K | Buy |
4,941
+354
| +8% | +$57.3K | ﹤0.01% | 2749 |
|
|
2020
Q4 | $666K | Sell |
4,587
-150
| -3% | -$22.8K | ﹤0.01% | 2701 |
|
|
2020
Q3 | $793K | Buy |
4,737
+625
| +15% | +$96.2K | ﹤0.01% | 2631 |
|
|
2020
Q2 | $586K | Buy |
4,112
+629
| +18% | +$75.6K | ﹤0.01% | 2812 |
|
|
2020
Q1 | $341K | Buy |
3,483
+548
| +19% | +$55.2K | ﹤0.01% | 2922 |
|
|
2019
Q4 | $256K | Buy |
2,935
+611
| +26% | +$61K | ﹤0.01% | 3111 |
|
|
2019
Q3 | $268K | Buy |
2,324
+369
| +19% | +$47.6K | ﹤0.01% | 3066 |
|
|
2019
Q2 | $310K | Buy |
1,955
+454
| +30% | +$69.7K | ﹤0.01% | 3164 |
|
|
2019
Q1 | $254K | Buy |
1,501
+455
| +43% | +$68.8K | ﹤0.01% | 3146 |
|
|
2018
Q4 | $134K | Buy |
1,046
+357
| +52% | +$71.2K | ﹤0.01% | 3195 |
|
|
2018
Q3 | $181K | Buy |
689
+183
| +36% | +$66.5K | ﹤0.01% | 3170 |
|
|
2018
Q2 | $226K | Buy |
506
+179
| +55% | +$117K | ﹤0.01% | 3049 |
|
|
2018
Q1 | $217K | Buy |
327
+1
| +0.3% | +$822 | ﹤0.01% | 3163 |
|
|
2017
Q4 | $319K | Buy |
326
+121
| +59% | +$104K | ﹤0.01% | 3007 |
|
|
2017
Q3 | $193K | Sell |
205
-13
| -6% | -$14.1K | ﹤0.01% | 3006 |
|
|
2017
Q2 | $260K | Sell |
218
-30
| -12% | -$37K | ﹤0.01% | 2937 |
|
|
2017
Q1 | $320K | Buy |
248
+172
| +226% | +$200K | ﹤0.01% | 2892 |
|
|
2016
Q4 | $69K | Buy |
+76
| New | +$63K | ﹤0.01% | 3137 |
|
Other funds holding SNOA
MCWS
GRP
Renaissance Technologies's SNOA Position: Q2 2026 in Review
Renaissance Technologies opened a new position in Sonoma Pharmaceuticals (SNOA) in Q2 2026: 40,468 shares worth $49.8K. The stake represents ﹤0.01% of the portfolio and ranks #3048 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in SNOA as recently as Q2 2025.
Renaissance Technologies first reported a position in SNOA in Q4 2016 and has held it in 30 quarters since. The position peaked at $793K in Q3 2020. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.
- Renaissance Technologies held 40,468 shares of Sonoma Pharmaceuticals worth $49.8K as of Q2 2026.
- Sonoma Pharmaceuticals was a new Renaissance Technologies position in Q2 2026.
- Sonoma Pharmaceuticals made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3048 holding.
- Renaissance Technologies first reported a position in Sonoma Pharmaceuticals in Q4 2016 and has held it in 30 quarters since.
- Renaissance Technologies's Sonoma Pharmaceuticals position peaked at $793K in Q3 2020.
- 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.